Cambridge Nutritional Sciences PLC
LSE:CNSL

Watchlist Manager
Cambridge Nutritional Sciences PLC Logo
Cambridge Nutritional Sciences PLC
LSE:CNSL
Watchlist
Price: 3.3 GBX 4.76% Market Closed
Market Cap: 7.9m GBX
Have any thoughts about
Cambridge Nutritional Sciences PLC?
Write Note

Intrinsic Value

The intrinsic value of one CNSL stock under the Base Case scenario is 4.97 GBX. Compared to the current market price of 3.3 GBX, Cambridge Nutritional Sciences PLC is Undervalued by 34%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CNSL Intrinsic Value
4.97 GBX
Undervaluation 34%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Cambridge Nutritional Sciences PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for CNSL cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about CNSL?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Cambridge Nutritional Sciences PLC

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Cambridge Nutritional Sciences PLC

Provide an overview of the primary business activities
of Cambridge Nutritional Sciences PLC.

What unique competitive advantages
does Cambridge Nutritional Sciences PLC hold over its rivals?

What risks and challenges
does Cambridge Nutritional Sciences PLC face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Cambridge Nutritional Sciences PLC.

Provide P/S
for Cambridge Nutritional Sciences PLC.

Provide P/E
for Cambridge Nutritional Sciences PLC.

Provide P/OCF
for Cambridge Nutritional Sciences PLC.

Provide P/FCFE
for Cambridge Nutritional Sciences PLC.

Provide P/B
for Cambridge Nutritional Sciences PLC.

Provide EV/S
for Cambridge Nutritional Sciences PLC.

Provide EV/GP
for Cambridge Nutritional Sciences PLC.

Provide EV/EBITDA
for Cambridge Nutritional Sciences PLC.

Provide EV/EBIT
for Cambridge Nutritional Sciences PLC.

Provide EV/OCF
for Cambridge Nutritional Sciences PLC.

Provide EV/FCFF
for Cambridge Nutritional Sciences PLC.

Provide EV/IC
for Cambridge Nutritional Sciences PLC.

Show me price targets
for Cambridge Nutritional Sciences PLC made by professional analysts.

What are the Revenue projections
for Cambridge Nutritional Sciences PLC?

How accurate were the past Revenue estimates
for Cambridge Nutritional Sciences PLC?

What are the Net Income projections
for Cambridge Nutritional Sciences PLC?

How accurate were the past Net Income estimates
for Cambridge Nutritional Sciences PLC?

What are the EPS projections
for Cambridge Nutritional Sciences PLC?

How accurate were the past EPS estimates
for Cambridge Nutritional Sciences PLC?

What are the EBIT projections
for Cambridge Nutritional Sciences PLC?

How accurate were the past EBIT estimates
for Cambridge Nutritional Sciences PLC?

Compare the revenue forecasts
for Cambridge Nutritional Sciences PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Cambridge Nutritional Sciences PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Cambridge Nutritional Sciences PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Cambridge Nutritional Sciences PLC compared to its peers.

Compare the P/E ratios
of Cambridge Nutritional Sciences PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Cambridge Nutritional Sciences PLC with its peers.

Analyze the financial leverage
of Cambridge Nutritional Sciences PLC compared to its main competitors.

Show all profitability ratios
for Cambridge Nutritional Sciences PLC.

Provide ROE
for Cambridge Nutritional Sciences PLC.

Provide ROA
for Cambridge Nutritional Sciences PLC.

Provide ROIC
for Cambridge Nutritional Sciences PLC.

Provide ROCE
for Cambridge Nutritional Sciences PLC.

Provide Gross Margin
for Cambridge Nutritional Sciences PLC.

Provide Operating Margin
for Cambridge Nutritional Sciences PLC.

Provide Net Margin
for Cambridge Nutritional Sciences PLC.

Provide FCF Margin
for Cambridge Nutritional Sciences PLC.

Show all solvency ratios
for Cambridge Nutritional Sciences PLC.

Provide D/E Ratio
for Cambridge Nutritional Sciences PLC.

Provide D/A Ratio
for Cambridge Nutritional Sciences PLC.

Provide Interest Coverage Ratio
for Cambridge Nutritional Sciences PLC.

Provide Altman Z-Score Ratio
for Cambridge Nutritional Sciences PLC.

Provide Quick Ratio
for Cambridge Nutritional Sciences PLC.

Provide Current Ratio
for Cambridge Nutritional Sciences PLC.

Provide Cash Ratio
for Cambridge Nutritional Sciences PLC.

What is the historical Revenue growth
over the last 5 years for Cambridge Nutritional Sciences PLC?

What is the historical Net Income growth
over the last 5 years for Cambridge Nutritional Sciences PLC?

What is the current Free Cash Flow
of Cambridge Nutritional Sciences PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Cambridge Nutritional Sciences PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Cambridge Nutritional Sciences PLC

Balance Sheet Decomposition
Cambridge Nutritional Sciences PLC

Current Assets 7.9m
Cash & Short-Term Investments 5.4m
Receivables 1.8m
Other Current Assets 607k
Non-Current Assets 6m
PP&E 514k
Intangibles 4.1m
Other Non-Current Assets 1.4m
Current Liabilities 1.4m
Accounts Payable 1.3m
Other Current Liabilities 123k
Non-Current Liabilities 2.8m
Long-Term Debt 25k
Other Non-Current Liabilities 2.7m
Efficiency

Earnings Waterfall
Cambridge Nutritional Sciences PLC

Revenue
9.8m GBP
Cost of Revenue
-3.7m GBP
Gross Profit
6m GBP
Operating Expenses
-6.6m GBP
Operating Income
-535k GBP
Other Expenses
207k GBP
Net Income
-328k GBP

Free Cash Flow Analysis
Cambridge Nutritional Sciences PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CNSL Profitability Score
Profitability Due Diligence

Cambridge Nutritional Sciences PLC's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Negative ROIC
Negative ROE
Negative Operating Income
31/100
Profitability
Score

Cambridge Nutritional Sciences PLC's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

CNSL Solvency Score
Solvency Due Diligence

Cambridge Nutritional Sciences PLC's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
54/100
Solvency
Score

Cambridge Nutritional Sciences PLC's solvency score is 54/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CNSL Price Targets Summary
Cambridge Nutritional Sciences PLC

Wall Street analysts forecast CNSL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CNSL is 10.2 GBX with a low forecast of 10.1 GBX and a high forecast of 10.5 GBX.

Lowest
Price Target
10.1 GBX
206% Upside
Average
Price Target
10.2 GBX
209% Upside
Highest
Price Target
10.5 GBX
218% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CNSL?

Click here to dive deeper.

Dividends

Cambridge Nutritional Sciences PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for CNSL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Cambridge Nutritional Sciences PLC Logo
Cambridge Nutritional Sciences PLC

Country

United Kingdom

Industry

Health Care

Market Cap

7.9m GBP

Dividend Yield

0%

Description

Cambridge Nutritional Sciences Plc is a holding company, which engages in the manufacture, development, and distribution of medical diagnostics products. The firm develops, manufactures and markets diagnostic products associated with food sensitivity and gut health. The firm serves healthcare professionals and the consumer directly with a focus on health and nutrition products.

Contact

CAMBRIDGESHIRE
Ely
Eden Research Park, Henry Crabb Road, Littleport
+441353862220
www.omegadx.com

IPO

2004-03-18

Employees

94

Officers

Interim CEO & Executive Director
Mr. James Cooper
Group Financial Controller
Mr. Iain Alexander James Logan
Managing Director of Omega Dx Asia Pvt Limited
Mr. Prashant Maniar
Company Secretary
Ms. Charlene Roderman
Global Ambassador - Life President
Mr. Andrew William Shepherd BSc.(Hons)

See Also

Discover More
What is the Intrinsic Value of one CNSL stock?

The intrinsic value of one CNSL stock under the Base Case scenario is 4.97 GBX.

Is CNSL stock undervalued or overvalued?

Compared to the current market price of 3.3 GBX, Cambridge Nutritional Sciences PLC is Undervalued by 34%.

Back to Top